Cargando…

Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assay

BACKGROUND: In major bleeding events, the new direct oral anticoagulants pose a great challenge for physicians. The aim of the study was to test for ex vivo reversal of the direct oral anticoagulant rivaroxaban with various non-specific reversal agents: prothrombin complex concentrate (PCC), activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schenk, B., Würtinger, P., Streif, W., Sturm, W., Fries, D., Bachler, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Cardiovascular
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091332/ https://www.ncbi.nlm.nih.gov/pubmed/27623677 http://dx.doi.org/10.1093/bja/aew259

Ejemplares similares

Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements
por: Meihandoest, Tamana, et al.
Publicado: (2021)

Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
por: Schenk, Bettina, et al.
Publicado: (2018)

Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry
por: Indirli, Rita, et al.
Publicado: (2020)

Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay
por: Carlo, Audrey, et al.
Publicado: (2022)

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases
por: Valke, Lars L. F. G., et al.
Publicado: (2022)

Detecting hypercoagulability in sepsis: thromboelastometry vs thrombomodulin-modified thrombin generation test
por: Osovskikh, VV, et al.
Publicado: (2015)

Mode of Delivery Does Not Influence Postpartum Hypercoagulability Measured by Thrombin Generation or Thromboelastometry
por: Guimicheva, Boriana, et al.
Publicado: (2020)

Assessment of Rotational Thromboelastometry and Thrombin Generation Assay to Identify Risk of High Blood Loss and Re-Operation After Cardiac Surgery
por: Jeong, Dajeong, et al.
Publicado: (2022)

Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature
por: Gehlen, Rachel, et al.
Publicado: (2023)

Editorial: Advances in thrombin generation
por: de Laat-Kremers, Romy, et al.
Publicado: (2023)

Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease
por: Feugray, Guillaume, et al.
Publicado: (2022)

Biological Variation in Rotational Thromboelastometry in Patients with Atrial Fibrillation Receiving Rivaroxaban
por: Božič Mijovski, Mojca, et al.
Publicado: (2022)

Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
por: Giffard-Quillon, Lorine, et al.
Publicado: (2020)

Whole Blood Thromboelastometry by ROTEM and Thrombin Generation by Genesia According to the Genotype and Clinical Phenotype in Congenital Fibrinogen Disorders
por: Szanto, Timea, et al.
Publicado: (2021)

Reversal of Bioprosthetic Aortic Valve Thrombosis Using Rivaroxaban—A Case Report
por: Sharma, Harish, et al.
Publicado: (2020)

Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay
por: Artang, Ramin, et al.
Publicado: (2017)

Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy
por: Touw, Carolina E., et al.
Publicado: (2023)

Use of oral rivaroxaban in cerebral venous thrombosis
por: Maqsood, Muhammad, et al.
Publicado: (2020)

Clinical use of thrombin generation assays
por: Binder, Nikolaus B., et al.
Publicado: (2021)

Intrinsic coagulation pathway-mediated thrombin generation in mouse whole blood
por: Konrath, Sandra, et al.
Publicado: (2022)

Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation
por: Horinaka, Shigeo, et al.
Publicado: (2017)

Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet‐dependent thrombin generation in cats
por: Lo, Sara T., et al.
Publicado: (2023)

Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model
por: Zentai, Christian, et al.
Publicado: (2015)

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Assessing the individual roles of FII, FV, and FX activity in the thrombin generation process
por: Bai, Cuicui, et al.
Publicado: (2022)

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study
por: Liu, Zhiyan, et al.
Publicado: (2022)

Stroke prevention with rivaroxaban in higher‐risk populations with atrial fibrillation
por: Diener, H.‐C., et al.
Publicado: (2015)

Rivaroxaban Effects Illustrate the Underestimated Importance of Activated Platelets in Thrombin Generation Assessed by Calibrated Automated Thrombography
por: Makhoul, Stephanie, et al.
Publicado: (2019)

Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography
por: Solomon, Cristina, et al.
Publicado: (2015)

Patients With Multiple Myeloma Have a Disbalanced Whole Blood Thrombin Generation Profile
por: Li, Li, et al.
Publicado: (2022)

Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated Thrombography
por: Zalewski, Jaroslaw, et al.
Publicado: (2020)

Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
por: Kleinegris, Marie-Claire F., et al.
Publicado: (2017)

A review of commercially available thrombin generation assays
por: Kintigh, Jeremy, et al.
Publicado: (2017)

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy
por: de Breet, C. P. D. M., et al.
Publicado: (2021)

Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass
por: Percy, Charles L., et al.
Publicado: (2015)

Circulating Small Extracellular Vesicles Profiling and Thrombin Generation as Potential Markers of Thrombotic Risk in Glioma Patients
por: Melnichnikova, Olga, et al.
Publicado: (2022)

Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations
por: Duarte, Rita Carolina Figueiredo, et al.
Publicado: (2017)

Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo
por: Perzborn, E, et al.
Publicado: (2014)

Assessment of DOAC in GEriatrics ( Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients
por: Foulon-Pinto, Geoffrey, et al.
Publicado: (2023)

Role of a thrombin generation assay in the prediction of infection severity
por: Elad, Boaz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rr1bi7h5s98d916l9ib5p49h03